CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Strassburger Philip C. General Counsel | Sale | −6,831 | $4.95 | $34K | 109,218 |
| 2024-01-31 | White Christopher G Chief Business Officer | Sale | −5,147 | $4.95 | $25K | 89,619 |
| 2024-01-31 | Mattessich Antony C. President and CEO | Sale | −18,338 | $4.95 | $91K | 427,943 |
| 2023-12-14 | SUMMER ROAD LLC 10% owner | Purchase | +1,538,461 | $3.25 | $5.0M | 7,660,550 |
| 2023-08-30 | Mattessich Antony C. President and CEO | Purchase | +6,500 | $3.81 | $25K | 6,500 |
| 2023-08-02 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +17,350 | 17,350 | ||
| 2023-07-10 | Graves Adrienne L Director | Grant or award | +24,000 | 24,000 | ||
| 2023-07-10 | Graves Adrienne L Director | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2023-07-07 | Ozden Rabia Gurses Chief Medical Officer | Sale | −832 | $4.93 | $4K | 100,531 |
| 2023-06-14 | Warden Charles M Director | Grant or award | +12,000 | 60,464 | ||
| 2023-06-14 | Warden Charles M Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-14 | Williams Leslie J. Director | Grant or award | +12,000 | 25,433 | ||
| 2023-06-14 | Williams Leslie J. Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-14 | RAINES MERILEE Director | Grant or award | +12,000 | 20,933 | ||
| 2023-06-14 | RAINES MERILEE Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-14 | LINDSTROM RICHARD L MD Director | Grant or award | +12,000 | 120,402 | ||
| 2023-06-14 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-14 | Hong Seung Suh Director | Grant or award | +12,000 | 20,933 | ||
| 2023-06-14 | Hong Seung Suh Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-14 | Heier Jeffrey S. Director | Grant or award | +12,000 | 59,933 |
Page 10 of 17 · 327 trades